SUT BEZI SARATONINING TRIPLE-NEGATIV (UCH MARTA MANFIY) SUBTIPIDA NEOADYUVANT KIMYOTERAPIYA FONIDA O‘SMA-INFILTRATSIYA QILUVCHI LIMFOTSITLAR (TILS) DINAMIKASINI BAHOLASH VA UNING METASTAZLANISH XAVFI BILAN BOG‘LIQLIGI

Authors

  • Shomirzayev Isroiljon Tolibjon o’gli Samarqand Davlat Tibbiyot Universiti
  • Jumonov Oybek Yormuhammad o’gli Samarqand Davlat Tibbiyot Universiti
  • Sadullayev Nasim Saloxiddin o’gli Samarqand Davlat Tibbiyot Universiti

Keywords:

triple-negativ sut bezi saratoni, neoadyuvant kimyoterapiya, o‘sma-infiltratsiya qiluvchi limfotsitlar (TILs), metastazlanish xavfi, patologik to‘liq regressiya.

Abstract

Ushbu tezisda triple-negativ sut bezi saratoni (TNSBS) bilan og‘rigan bemorlarda neoadyuvant kimyoterapiya (NAKT) jarayonida o‘smainfiltratsiya qiluvchi limfotsitlar (TILs) darajasining dinamik o‘zgarishi va uning uzoq muddatli metastazlanish xavfi bilan bog‘liqligi tahlil qilinadi. TNSBS o‘zining agressiv kechishi va gormonal nishonlarning yo‘qligi bilan ajralib turadi. Klinik tadqiqotlar ma’lumotlariga ko‘ra, NAKTdan oldingi va keyingi TILs ko‘rsatkichlari immunologik javobning muhim prognostik markeri hisoblanadi. Tezisda TILs darajasining yuqoriligi patologik to‘liq regressiya (pCR) ko‘rsatkichini oshirishi va metastazlanish xavfini sezilarli darajada kamaytirishi haqidagi faktik ma’lumotlar umumlashtirilgan.

References

Foulkes, W. D., Smith, I. E., & Reis-Filho, J. S. (2010). Triplenegative breast cancer. New England Journal of Medicine, 363(20), 1938-1948.

Liedtke, C., Mazouni, C., & Hess, K. R. (2008). Response to neoadjuvant therapy and long-term survival in patients with triple-negative breast cancer. Journal of Clinical Oncology, 26(8), 1275-1281.

Denkert, C., von Minckwitz, G., & Brase, J. C. (2015). Tumorinfiltrating lymphocytes and response to neoadjuvant chemotherapy with or without carboplatin in triple-negative breast cancer. Journal of Clinical Oncology, 33(9), 983-991.

Salgado, R., Denkert, C., & Campbell, C. (2015). The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014. Annals of Oncology, 26(2), 259-271.

Dieci, M. V., Mathieu, M. C., & Guarneri, V. (2014). Prognostic and predictive value of tumor-infiltrating lymphocytes in carcinoma of the breast. The Breast, 23(2), 115-125.

Ogston, K. N., Miller, I. D., & Payne, S. (2003). A new histological grading system to assess response of breast cancers to primary chemotherapy. The Breast, 12(5), 320-327.

Adams, S., Gray, R. J., & Demaria, S. (2014). Prognostic value of tumor-infiltrating lymphocytes in triple-negative breast cancers from two phase III randomized adjuvant trials. Journal of Clinical Oncology, 32(27), 2959-2966.

Hida, A. I., Sagara, Y., & Yotsumoto, D. (2016). Prognostic and predictive impacts of tumor-infiltrating lymphocytes differing between triplenegative and HER2-positive breast cancers treated with neoadjuvant chemotherapy.

Breast Cancer Research and Treatment, 158(3), 429-439.

Loi, S., Michiels, S., & Salgado, R. (2019). Tumor-infiltrating lymphocytes are prognostic in triple-negative breast cancer and predictive for trastuzumab benefit in HER2-positive breast cancer. Annals of Oncology, 30(8), 1280-1288.

Galluzzi, L., Buqué, A., & Kepp, O. (2017). Immunogenic cell death in cancer therapy. Nature Reviews Immunology, 17(2), 97-111.

Mittendorf, E. A., Philips, A. V., & Meric-Bernstam, F. (2014). PD-L1 expression in triple-negative breast cancer. Cancer Immunology Research, 2(4), 361-370.

Schmid, P., Adams, S., & Rugo, H. S. (2018). Atezolizumab and nabpaclitaxel in advanced triple-negative breast cancer. New England Journal of Medicine, 379(22), 2108-2121.

Downloads

Published

2026-06-09

How to Cite

Shomirzayev Isroiljon Tolibjon o’gli, Jumonov Oybek Yormuhammad o’gli, & Sadullayev Nasim Saloxiddin o’gli. (2026). SUT BEZI SARATONINING TRIPLE-NEGATIV (UCH MARTA MANFIY) SUBTIPIDA NEOADYUVANT KIMYOTERAPIYA FONIDA O‘SMA-INFILTRATSIYA QILUVCHI LIMFOTSITLAR (TILS) DINAMIKASINI BAHOLASH VA UNING METASTAZLANISH XAVFI BILAN BOG‘LIQLIGI. IQRO , 22(01), 1797–1801. Retrieved from https://wordlyknowledge.uz/index.php/iqro/article/view/8481